ARDELYX, INC. Operating Lease Liability
ARDELYX, INC. (ARDX) had Operating Lease Liability of $4.37 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability $4.37M.
- 2026-03-31: Operating Lease, Liability $4.75M.
- 2025-12-31: Operating Lease, Liability $5.12M.
- 2025-09-30: Operating Lease, Liability $5.47M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $4.37M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $4.75M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $5.12M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $5.47M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $5.20M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $3.81M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $2.58M 10-K · filed 2026-02-19 |
| 2024-09-30 | $3.79M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $4.65M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $5.09M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $6.16M 10-K · filed 2025-02-20 |
| 2023-09-30 | $7.21M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $7.86M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $8.81M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $9.75M 10-K · filed 2024-02-22 |
| 2022-09-30 | $10.67M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $11.55M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $12.40M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $13.24M 10-K · filed 2023-03-02 |
| 2021-09-30 | $14.06M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $14.73M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $1.81M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $2.53M 10-K · filed 2022-02-28 |
| 2020-11-30 | $400.00K 10-K · filed 2021-03-08 |
| 2020-09-30 | $2.77M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.43M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $4.07M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $4.68M 10-K · filed 2020-03-06 |
| 2019-09-30 | $5.27M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $5.75M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $6.17M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |